Navigation Links
GlaxoSmithKline Announces Data on TYKERB(R) (Lapatinib) Plus Capecitabine for the Treatment of HER2 Positive Breast Cancer Brain Metastases
Date:12/17/2007

n metastases.

"I know first hand that HER2-positive breast cancer can have unique, difficult-to-treat complications. Brain metastases can be particularly devastating for patients, as they may cause blurred vision, speech impairments and can limit patients' ability to engage in even simple day-to-day activities," said Christine Druther, MSPH, founder and president, HER2 Support Group. "We look forward to the results of any and all research in the treatment of HER2-positive breast cancer and its complications."

Data Presented on Abstract 6076(1)

In this study, the combination of TYKERB plus capecitabine showed a reduction in HER2-positive breast cancer that had spread to the brain and had progressed on TYKERB alone. Preliminary results are available from the initial 49 patients who enrolled in the TYKERB plus capecitabine extension arm as of March 2007. Exploratory analysis revealed 18 patients (37 percent) experienced at least a 20 percent volume reduction in brain metastases, without progression of their disease outside of the brain, increase in steroid requirements or worsening of neurological signs or symptoms, and a median reduction in brain metastases of 4.8 cm(3). Of these 18 patients, 10 patients (20 percent) experienced at least a 50 percent volume reduction in brain metastases with a median reduction in brain metastases of 7.1 cm(3). As of September 2007, three patients remained on the parent study with TYKERB monotherapy and of the 51 patients enrolled in the extension arm with TYKERB plus capecitabine, eight remained on lapatinib plus capecitabine.

Of the 51 patients enrolled in the extension arm, 10 (20 percent) who received TYKERB plus capecitabine experienced a partial response and 20 patients (39 percent) achieved stable disease. The disease progressed in fifteen patients (29 percent) who received the combination. The status of 6 patients (12%) was unknown at the time of reporting.

The most commonly reported Grade 1/2
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. AUDIO from Medialink and GlaxoSmithKline: Fiber Key in Managing Irritable Bowel Syndrome (IBS) Symptoms
3. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
4. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
5. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
6. BioWa Announces Licensing of BioWas POTELLIGENT(R) Technology by GlaxoSmithkline for Use in Antibody Research and Development
7. GlaxoSmithKline Consumer Healthcare Recommends Maintaining FDAS Current Two-Class Drug System
8. GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
11. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013 With bed bugs' presence come ... although bed bugs need to be eliminated, one must make ... a person's health. And so to help bed bug sufferers ... get rid of bed bugs without using harmful pesticides. ... spray it called Bed Bug Bully. , According to My ...
(Date:5/20/2013)... WOBURN, Mass. , May 20, 2013   ... Frederick W. Driscoll to its ... more than 30 years of financial management experience with ... joining Flexion, Mr. Driscoll was chief financial officer for ... a team that secured more than $250 million through ...
(Date:5/20/2013)... FL (PRWEB) May 20, 2013 Researchers from ... in the connection between lower back pain, and the acne ... P.acnes in the system the bacteria seek out oxygen deprived ... incurred in the spinal column, P.acnes has the ability to ... , Fernando Perez, a spokesman for “ The best ...
(Date:5/20/2013)... Kitware, a leader in data visualization, today ... exploration of hospital costs across the United States ... recent release of “Medicare Provider Charge Data,” a dataset ... from the Centers for Medicare & Medicaid Services. , ... hospitals across the country has sparked considerable controversy; however, ...
Breaking Biology Technology:New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2Adult Acne Treatment, Probiotic Action Shares New Insight How Treating Acne May Help Reduce Body Pain 2Kitware Enables Interactive Exploration of CMS Medicare Data 2
... Leaders Join Forces to Promote Early Detection ... and Treatment of Hypertension in the UK, ... Ltd. (Tel Aviv Stock Exchange: INCR), and Omron Healthcare (UK),Ltd., ... to strengthen the link between hypertension diagnostics and,therapies in the ...
... Blood found 92 percent reduction in ... incidence ... a rare,blood disorder called PNH experienced a 92 percent reduction ... (eculizumab), according to an analysis of clinical studies,recently published online ...
... 20 - Essential, Structure-Searchable Chemistry ... to Researchers Elsevier Information Systems GmbH, ... of scientific, technical and medical information,is pleased ... the CrossFire Beilstein,database will contain more than ...
Cached Biology Technology:InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom 2InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom 3InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom 4PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 2PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 3PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 4PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 5PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 6PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 7PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 8CrossFire Beilstein Database Exceeds Ten Million Compounds 2CrossFire Beilstein Database Exceeds Ten Million Compounds 3
(Date:5/20/2013)... also commonly resistant to antimicrobial substances made by ... mBio , the online open-access journal of ... and host antimicrobials LL-37 and lysozyme, which help ... that patients with life-threatening multi-drug resistant infections are ... is a last-line drug for treating several kinds ...
(Date:5/20/2013)... Science Foundation (NSF) planning grant will help establish the ... program of the University of Illinois at Urbana-Champaign and ... will be devoted to research in drying moist, porous ... and paper products; chemical products; textiles; and biopharmaceuticals," said ... science and human nutrition and the Illinois site director. ...
(Date:5/19/2013)... a strain of electricity-producing bacteria that can grow using ... dioxide as its sole source of carbon. Researchers ... at the 113th General Meeting of the American Society ... current production solely on hydrogen," says Amit Kumar, a ... are part of the Lovley Lab Group at the ...
Breaking Biology News(10 mins):Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3NSF approves planning grant for Center for Advanced Research in Drying 2
... Fla. (June 16, 2009) To determine if guided ... and functional recovery, researchers at the University of Pittsburgh ... the injured peripheral nerves of laboratory rats. ... shown to be an abundant source of post-natal precursor ...
... engineers have taken a first step toward a minimally ... heat administered from the end of a catheter. ... possible to treat brain tumors without the side effects ... or radiation. The bioengineers designed and built an ...
... University of California, Berkeley, researchers have found what they ... of the puzzle about how stress causes sexual dysfunction ... of stress hormones - glucocorticoids such as cortisol - ... hormone (GnRH), and subsequently suppresses sperm count, ovulation and ...
Cached Biology News:Peripheral nerve repair with fat precursor cells led to wider nerves and less muscle atrophy 2Potential for non-invasive brain tumor treatment 2Stress puts double whammy on reproductive system, fertility 2Stress puts double whammy on reproductive system, fertility 3
... The DNA Engine Dyad instrument is the ... Featuring MJ's world-class thermal performance, the ... display, as well as point-and-click navigation via ... Dyad can be easily and economically expanded ...
...
...
...
Biology Products: